Cite
N-Butyl-l-deoxynojirimycin (l-NBDNJ): Synthesis of an Allosteric Enhancer of α-Glucosidase Activity for the Treatment of Pompe Disease.
MLA
D’Alonzo, Daniele, et al. “N-Butyl-l-Deoxynojirimycin (l-NBDNJ): Synthesis of an Allosteric Enhancer of α-Glucosidase Activity for the Treatment of Pompe Disease.” Journal of Medicinal Chemistry, vol. 60, no. 23, Dec. 2017, pp. 9462–69. EBSCOhost, https://doi.org/10.1021/acs.jmedchem.7b00646.
APA
D’Alonzo, D., De Fenza, M., Porto, C., Iacono, R., Huebecker, M., Cobucci-Ponzano, B., Priestman, D. A., Platt, F., Parenti, G., Moracci, M., Palumbo, G., & Guaragna, A. (2017). N-Butyl-l-deoxynojirimycin (l-NBDNJ): Synthesis of an Allosteric Enhancer of α-Glucosidase Activity for the Treatment of Pompe Disease. Journal of Medicinal Chemistry, 60(23), 9462–9469. https://doi.org/10.1021/acs.jmedchem.7b00646
Chicago
D’Alonzo, Daniele, Maria De Fenza, Caterina Porto, Roberta Iacono, Mylene Huebecker, Beatrice Cobucci-Ponzano, David A. Priestman, et al. 2017. “N-Butyl-l-Deoxynojirimycin (l-NBDNJ): Synthesis of an Allosteric Enhancer of α-Glucosidase Activity for the Treatment of Pompe Disease.” Journal of Medicinal Chemistry 60 (23): 9462–69. doi:10.1021/acs.jmedchem.7b00646.